title: Adult gliosarcoma: epidemiology, natural history, and factors associated with outcome.
abstract: The epidemiology and natural history of adult gliosarcomas (GSMs), as well as patient and treatment factors associated with outcome, are ill defined. Patients over 20 years of age with GSM diagnosed from 1988 to 2004 were identified in the Surveillance, Epidemiology, and End Results (SEER) database. Kaplan-Meier survival analysis and Cox models were used to examine outcomes. Similar analyses were conducted for patients diagnosed with glioblastoma (GBM) over the same time period. GSM represented 2.2% of the 16,388 patients identified with either GSM or GBM. No significant differences between GSM and GBM were identified with respect to age, gender, race, tumor size, or use of adjuvant radiation therapy (RT). Patients with GSM were more likely to have temporal lobe involvement and undergo some form of tumor resection. The most important analyzed factors influencing GSM overall survival were age, extent of resection, and use of adjuvant RT. After adjusting for factors impacting overall survival, the prognosis for GSM appears slightly worse than for GBM (HR = 1.17, 95% CI, 1.05-1.31). GSM is a rare malignancy that presents very similarly to GBM with a slightly greater propensity for temporal lobe involvement. Optimal treatment remains to be defined. However, these retrospective findings suggest tumor excision, as opposed to biopsy only, and adjuvant RT may improve outcome. Despite therapy, prognosis remains dismal and outcomes may be inferior to those seen in GBM patients.
authors.affiliation: Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA. kozak@humonc.wisc.edu
authors.forename: Kevin R
authors.initials: KR
authors.lastname: Kozak
authors.forename: Anand
authors.initials: A
authors.lastname: Mahadevan
authors.forename: John S
authors.initials: JS
authors.lastname: Moody
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001932:Brain Neoplasms / Q000453:epidemiology* / Q000532:radiotherapy; D005260:Female; D018316:Gliosarcoma / Q000453:epidemiology* / Q000532:radiotherapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D017063:Outcome Assessment, Health Care; D011379:Prognosis; D018714:Radiotherapy, Adjuvant; D018426:SEER Program; D015996:Survival Rate; D016896:Treatment Outcome; D055815:Young Adult
references.citation: J Neurooncol. 2005 Aug;74(1):59-63
references.pmid: 16078109
references.citation: AJNR Am J Neuroradiol. 1987 Jan-Feb;8(1):117-22
references.pmid: 3101453
references.citation: Cancer. 1995 Jun 15;75(12):2910-8
references.pmid: 7773942
references.citation: Clin Neurol Neurosurg. 2006 Feb;108(2):178-86
references.pmid: 16412839
references.citation: J Neurosurg. 1993 May;78(5):767-75
references.pmid: 8468607
references.citation: J Neurosurg. 1998 Sep;89(3):425-30
references.pmid: 9724117
references.citation: Radiother Oncol. 2001 Oct;61(1):57-64
references.pmid: 11578729
references.citation: Pediatr Neurosurg. 1993 Mar-Apr;19(2):57-62
references.pmid: 8443097
references.citation: Br J Neurosurg. 1995 Apr;9(2):171-8
references.pmid: 7632363
references.citation: Acta Oncol. 2007;46(8):1202-4
references.pmid: 17851847
references.citation: N Engl J Med. 2005 Mar 10;352(10):987-96
references.pmid: 15758009
references.citation: J Natl Cancer Inst. 1993 May 5;85(9):704-10
references.pmid: 8478956
references.citation: J Neurosurg. 1976 Oct;45(4):398-408
references.pmid: 956876
references.citation: J Neurosurg. 2003 Sep;99(3):467-73
references.pmid: 12959431
references.citation: Am J Pathol. 1955 Jul-Aug;31(4):633-53
references.pmid: 14388124
references.citation: Cancer. 1991 May 1;67(9):2342-9
references.pmid: 1849447
references.citation: Clin Neurol Neurosurg. 1998 Jun;100(2):153-9
references.pmid: 9746306
references.citation: Indian J Med Res. 1997 Sep;106:229-35
references.pmid: 9378529
references.citation: J Neuropathol Exp Neurol. 1978 May;37(3):300-13
references.pmid: 660217
references.citation: Neurosurgery. 1991 Sep;29(3):385-8; discussion 388-9
references.pmid: 1833663